BIIBBiogen Inc.
$226.68+1.70%
0.1% Above PivotData as of Oct 7, 2026
Loading theme radar
Biotech & Healthcare Stocks
Large-cap pharma, gene editing, medical devices, life sciences tools, and AI-driven drug discovery across the healthcare stack.
3M Return+5.8%
YTD Return+26.5%Year to date
vs SPY (3M)+2.1%Theme minus SPY
Total Stocks46Curated universe
Setup Distribution
Breaking Out4
Near Pivot5
Forming5
Total Setups14
Theme vs SPY (3M)
Biotech & Healthcare Stocks+5.8%
SPY+3.7%
Top Setups in Biotech & Healthcare Stocks(3 of 14 shown)
Open theme screener
HUMHumana Inc.
$407.34+0.76%
1.8% To PivotData as of Oct 7, 2026
VEEVVeeva Systems Inc.
$281.31-0.77%
3.5% To PivotData as of Oct 7, 2026
Unlock all 14 setups in Biotech & Healthcare Stocks
See every active, near-pivot, and forming setup with full charts, advanced filtering, historical performance, alerts, and much more.
All setups and full details Advanced filters & sorting Real-time alerts & notifications
After your 7-day trial: $10/month billed annually ($120/year), or $15/month. No credit card required. No charge unless you upgrade.
Today in Biotech & Healthcare Stocks
Data as of Oct 7, 2026Theme Performance
| Today (1D) | +0.70% |
| 5D | -1.31% |
| 1M | +1.70% |
| 3M | +5.84% |
| YTD | +26.48% |
| 1Y | +38.52% |
| vs SPY Benchmark | |
| Today (1D) | +0.14% |
| 1M | -0.02% |
| YTD | +12.23% |
Top Movers
Theme News
3 of the Best Growth Stocks to Buy in October 2026
fool.com · 1d ago$ABBV
HSBC Thinks AbbVie Can Climb to $315. Here's the Bull Case in Plain English.
fool.com · 1d ago$ABBV
AbbVie's Epcoritamab Combo Shows PFS Benefit in Frontline DLBCL
zacks.com · 1d ago$ABBV
Setup coverage is limited to 3 free previews. Rows marked Pro are outside this preview. Unlock Pro to see setup coverage across all 46 stocks.
| # | Ticker | Company | Price | % Change | RS Rating | Market Cap | Setups | Status | Watch |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Humana Inc. | $407.34 | +0.76% | 91 | $48.91B | (1) | Near Pivot | ||
| 2 | Veeva Systems Inc. | $281.41 | -0.74% | 91 | $45.71B | (1) | Forming | ||
| 3 | Biogen Inc. | $226.77 | +1.74% | 79 | $33.51B | (1) | Breaking Out | ||
| 4 | Eli Lilly and Company | $1,190.26 | +2.83% | 70 | $1.12T | Pro | Pro | ||
| 5 | AbbVie Inc. | $273.75 | +2.65% | 79 | $483.66B | Pro | Pro | ||
| 6 | Merck & Co., Inc. | $143.22 | +0.90% | 82 | $353.72B | Pro | Pro | ||
| 7 | UnitedHealth Group Incorporated | $380.93 | +1.23% | 66 | $345.94B | Pro | Pro | ||
| 8 | Thermo Fisher Scientific Inc. | $661.48 | +0.75% | 83 | $245.82B | Pro | Pro |
About Biotech & Healthcare Stocks
US biotech and healthcare stocks screened by market data, analyst coverage, and pipeline depth — large-cap pharma, gene therapy, medical devices, and AI-driven drug discovery.
46 StocksIn this theme
14 SetupsAcross 3 states
Updated DailyAfter market close (~8PM ET)
Popular Segments in this theme
Financial Data & Software Notice: VCP Scanner is an educational financial research database and stock screening software platform. VCP Scanner does not generate, recommend, or package trade decisions, buy/sell signals, or personalized investment advice. Theme baskets are quantitative metric rules, not managed funds or portfolio recommendations. See our Terms of Service and Privacy Policy.